context stringlengths 21 33.9k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
A valuation allowance was recorded to adjust deferred tax assets to the amount that the Company believes is more likely than not to be realized. Valuation allowances had a net increase of $ 24 million in 2024, and a net decrease of $ 110 million, and $ 1 million in 2023, and 2022, respectively. Adjustments of the beginning of the year balances of valuation allowances had no impact to the income tax expense in 2024. Adjustments of the beginning of the year balances of valuation allowances decreased income tax expense by $ 94 million in 2023 and $ 5 million in 2022. Approximately 10 % of the Company’s net operating loss carryforwards expire from 2025 through 2038, and the remaining 90 % are unlimited. The gross deferred tax assets of the potential tax benefit from net operating loss carryforwards at the end of 2024 is primarily comprised of non-U.S. tax benefits of $ 380 million. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> A valuation allowance was recorded to adjust deferred tax assets to the amount that the Company believes is more likely than not to be realized. Valuation allowances had a net increase of $ 24 million in 2024, and a net decrease of $ 110 million, and $ 1 million in 2023, and 2022, respectively. Adjustments of the beginning of the year balances of valuation allowances had no impact to the income tax expense in 2024. Adjustments of the beginning of the year balances of valuation allowances decreased income tax expense by $ 94 million in 2023 and $ 5 million in 2022. Approximately 10 % of the Company’s net operating loss carryforwards expire from 2025 through 2038, and the remaining 90 % are unlimited. The gross deferred tax assets of the potential tax benefit from net operating loss carryforwards at the end of 2024 is primarily comprised of non-U.S. tax benefits of $ 380 million. </context> | us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance |
A valuation allowance was recorded to adjust deferred tax assets to the amount that the Company believes is more likely than not to be realized. Valuation allowances had a net increase of $ 24 million in 2024, and a net decrease of $ 110 million, and $ 1 million in 2023, and 2022, respectively. Adjustments of the beginning of the year balances of valuation allowances had no impact to the income tax expense in 2024. Adjustments of the beginning of the year balances of valuation allowances decreased income tax expense by $ 94 million in 2023 and $ 5 million in 2022. Approximately 10 % of the Company’s net operating loss carryforwards expire from 2025 through 2038, and the remaining 90 % are unlimited. The gross deferred tax assets of the potential tax benefit from net operating loss carryforwards at the end of 2024 is primarily comprised of non-U.S. tax benefits of $ 380 million. | text | 94 | monetaryItemType | text: <entity> 94 </entity> <entity type> monetaryItemType </entity type> <context> A valuation allowance was recorded to adjust deferred tax assets to the amount that the Company believes is more likely than not to be realized. Valuation allowances had a net increase of $ 24 million in 2024, and a net decrease of $ 110 million, and $ 1 million in 2023, and 2022, respectively. Adjustments of the beginning of the year balances of valuation allowances had no impact to the income tax expense in 2024. Adjustments of the beginning of the year balances of valuation allowances decreased income tax expense by $ 94 million in 2023 and $ 5 million in 2022. Approximately 10 % of the Company’s net operating loss carryforwards expire from 2025 through 2038, and the remaining 90 % are unlimited. The gross deferred tax assets of the potential tax benefit from net operating loss carryforwards at the end of 2024 is primarily comprised of non-U.S. tax benefits of $ 380 million. </context> | us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance |
A valuation allowance was recorded to adjust deferred tax assets to the amount that the Company believes is more likely than not to be realized. Valuation allowances had a net increase of $ 24 million in 2024, and a net decrease of $ 110 million, and $ 1 million in 2023, and 2022, respectively. Adjustments of the beginning of the year balances of valuation allowances had no impact to the income tax expense in 2024. Adjustments of the beginning of the year balances of valuation allowances decreased income tax expense by $ 94 million in 2023 and $ 5 million in 2022. Approximately 10 % of the Company’s net operating loss carryforwards expire from 2025 through 2038, and the remaining 90 % are unlimited. The gross deferred tax assets of the potential tax benefit from net operating loss carryforwards at the end of 2024 is primarily comprised of non-U.S. tax benefits of $ 380 million. | text | 5 | monetaryItemType | text: <entity> 5 </entity> <entity type> monetaryItemType </entity type> <context> A valuation allowance was recorded to adjust deferred tax assets to the amount that the Company believes is more likely than not to be realized. Valuation allowances had a net increase of $ 24 million in 2024, and a net decrease of $ 110 million, and $ 1 million in 2023, and 2022, respectively. Adjustments of the beginning of the year balances of valuation allowances had no impact to the income tax expense in 2024. Adjustments of the beginning of the year balances of valuation allowances decreased income tax expense by $ 94 million in 2023 and $ 5 million in 2022. Approximately 10 % of the Company’s net operating loss carryforwards expire from 2025 through 2038, and the remaining 90 % are unlimited. The gross deferred tax assets of the potential tax benefit from net operating loss carryforwards at the end of 2024 is primarily comprised of non-U.S. tax benefits of $ 380 million. </context> | us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance |
A valuation allowance was recorded to adjust deferred tax assets to the amount that the Company believes is more likely than not to be realized. Valuation allowances had a net increase of $ 24 million in 2024, and a net decrease of $ 110 million, and $ 1 million in 2023, and 2022, respectively. Adjustments of the beginning of the year balances of valuation allowances had no impact to the income tax expense in 2024. Adjustments of the beginning of the year balances of valuation allowances decreased income tax expense by $ 94 million in 2023 and $ 5 million in 2022. Approximately 10 % of the Company’s net operating loss carryforwards expire from 2025 through 2038, and the remaining 90 % are unlimited. The gross deferred tax assets of the potential tax benefit from net operating loss carryforwards at the end of 2024 is primarily comprised of non-U.S. tax benefits of $ 380 million. | text | 380 | monetaryItemType | text: <entity> 380 </entity> <entity type> monetaryItemType </entity type> <context> A valuation allowance was recorded to adjust deferred tax assets to the amount that the Company believes is more likely than not to be realized. Valuation allowances had a net increase of $ 24 million in 2024, and a net decrease of $ 110 million, and $ 1 million in 2023, and 2022, respectively. Adjustments of the beginning of the year balances of valuation allowances had no impact to the income tax expense in 2024. Adjustments of the beginning of the year balances of valuation allowances decreased income tax expense by $ 94 million in 2023 and $ 5 million in 2022. Approximately 10 % of the Company’s net operating loss carryforwards expire from 2025 through 2038, and the remaining 90 % are unlimited. The gross deferred tax assets of the potential tax benefit from net operating loss carryforwards at the end of 2024 is primarily comprised of non-U.S. tax benefits of $ 380 million. </context> | us-gaap:DeferredTaxAssetsOperatingLossCarryforwards |
Of the total unrecognized tax benefits at December 31, 2024, 2023, and 2022, $ 111 million, $ 122 million and $ 94 million, respectively, represent the amount that, if recognized, would favorably affect the effective tax rate in any future periods. The total gross amount of accrued interest and penalties, before any applicable federal benefit, was $ 45 million at December 31, 2024, and $ 48 million at December 31, 2023 and 2022. | text | 111 | monetaryItemType | text: <entity> 111 </entity> <entity type> monetaryItemType </entity type> <context> Of the total unrecognized tax benefits at December 31, 2024, 2023, and 2022, $ 111 million, $ 122 million and $ 94 million, respectively, represent the amount that, if recognized, would favorably affect the effective tax rate in any future periods. The total gross amount of accrued interest and penalties, before any applicable federal benefit, was $ 45 million at December 31, 2024, and $ 48 million at December 31, 2023 and 2022. </context> | us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate |
Of the total unrecognized tax benefits at December 31, 2024, 2023, and 2022, $ 111 million, $ 122 million and $ 94 million, respectively, represent the amount that, if recognized, would favorably affect the effective tax rate in any future periods. The total gross amount of accrued interest and penalties, before any applicable federal benefit, was $ 45 million at December 31, 2024, and $ 48 million at December 31, 2023 and 2022. | text | 122 | monetaryItemType | text: <entity> 122 </entity> <entity type> monetaryItemType </entity type> <context> Of the total unrecognized tax benefits at December 31, 2024, 2023, and 2022, $ 111 million, $ 122 million and $ 94 million, respectively, represent the amount that, if recognized, would favorably affect the effective tax rate in any future periods. The total gross amount of accrued interest and penalties, before any applicable federal benefit, was $ 45 million at December 31, 2024, and $ 48 million at December 31, 2023 and 2022. </context> | us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate |
Of the total unrecognized tax benefits at December 31, 2024, 2023, and 2022, $ 111 million, $ 122 million and $ 94 million, respectively, represent the amount that, if recognized, would favorably affect the effective tax rate in any future periods. The total gross amount of accrued interest and penalties, before any applicable federal benefit, was $ 45 million at December 31, 2024, and $ 48 million at December 31, 2023 and 2022. | text | 94 | monetaryItemType | text: <entity> 94 </entity> <entity type> monetaryItemType </entity type> <context> Of the total unrecognized tax benefits at December 31, 2024, 2023, and 2022, $ 111 million, $ 122 million and $ 94 million, respectively, represent the amount that, if recognized, would favorably affect the effective tax rate in any future periods. The total gross amount of accrued interest and penalties, before any applicable federal benefit, was $ 45 million at December 31, 2024, and $ 48 million at December 31, 2023 and 2022. </context> | us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate |
Of the total unrecognized tax benefits at December 31, 2024, 2023, and 2022, $ 111 million, $ 122 million and $ 94 million, respectively, represent the amount that, if recognized, would favorably affect the effective tax rate in any future periods. The total gross amount of accrued interest and penalties, before any applicable federal benefit, was $ 45 million at December 31, 2024, and $ 48 million at December 31, 2023 and 2022. | text | 45 | monetaryItemType | text: <entity> 45 </entity> <entity type> monetaryItemType </entity type> <context> Of the total unrecognized tax benefits at December 31, 2024, 2023, and 2022, $ 111 million, $ 122 million and $ 94 million, respectively, represent the amount that, if recognized, would favorably affect the effective tax rate in any future periods. The total gross amount of accrued interest and penalties, before any applicable federal benefit, was $ 45 million at December 31, 2024, and $ 48 million at December 31, 2023 and 2022. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued |
The target asset allocation for the U.S. plans is 50 % equities and equity alternatives and 50 % fixed income. At December 31, 2024, the actual allocation for the U.S. plans was 51 % equities and equity alternatives and 49 % fixed income. The target asset allocation for the U.K. plans, which comprise approximately 78 % of non-U.S. plan assets, is 12 % equities and equity alternatives and 88 % fixed income. At December 31, 2024, the actual allocation for the U.K. plans was 12 % equities and equity alternatives and 88 % fixed income. The assets of the Company's defined benefit plans are diversified and are managed in accordance with applicable laws and with the goal of maximizing the plans' asset returns within acceptable risk parameters. The Company uses threshold-based portfolio re-balancing to ensure the actual portfolio remains consistent with target asset allocation ranges. | text | 50 | percentItemType | text: <entity> 50 </entity> <entity type> percentItemType </entity type> <context> The target asset allocation for the U.S. plans is 50 % equities and equity alternatives and 50 % fixed income. At December 31, 2024, the actual allocation for the U.S. plans was 51 % equities and equity alternatives and 49 % fixed income. The target asset allocation for the U.K. plans, which comprise approximately 78 % of non-U.S. plan assets, is 12 % equities and equity alternatives and 88 % fixed income. At December 31, 2024, the actual allocation for the U.K. plans was 12 % equities and equity alternatives and 88 % fixed income. The assets of the Company's defined benefit plans are diversified and are managed in accordance with applicable laws and with the goal of maximizing the plans' asset returns within acceptable risk parameters. The Company uses threshold-based portfolio re-balancing to ensure the actual portfolio remains consistent with target asset allocation ranges. </context> | us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage |
The target asset allocation for the U.S. plans is 50 % equities and equity alternatives and 50 % fixed income. At December 31, 2024, the actual allocation for the U.S. plans was 51 % equities and equity alternatives and 49 % fixed income. The target asset allocation for the U.K. plans, which comprise approximately 78 % of non-U.S. plan assets, is 12 % equities and equity alternatives and 88 % fixed income. At December 31, 2024, the actual allocation for the U.K. plans was 12 % equities and equity alternatives and 88 % fixed income. The assets of the Company's defined benefit plans are diversified and are managed in accordance with applicable laws and with the goal of maximizing the plans' asset returns within acceptable risk parameters. The Company uses threshold-based portfolio re-balancing to ensure the actual portfolio remains consistent with target asset allocation ranges. | text | 51 | percentItemType | text: <entity> 51 </entity> <entity type> percentItemType </entity type> <context> The target asset allocation for the U.S. plans is 50 % equities and equity alternatives and 50 % fixed income. At December 31, 2024, the actual allocation for the U.S. plans was 51 % equities and equity alternatives and 49 % fixed income. The target asset allocation for the U.K. plans, which comprise approximately 78 % of non-U.S. plan assets, is 12 % equities and equity alternatives and 88 % fixed income. At December 31, 2024, the actual allocation for the U.K. plans was 12 % equities and equity alternatives and 88 % fixed income. The assets of the Company's defined benefit plans are diversified and are managed in accordance with applicable laws and with the goal of maximizing the plans' asset returns within acceptable risk parameters. The Company uses threshold-based portfolio re-balancing to ensure the actual portfolio remains consistent with target asset allocation ranges. </context> | us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations |
The target asset allocation for the U.S. plans is 50 % equities and equity alternatives and 50 % fixed income. At December 31, 2024, the actual allocation for the U.S. plans was 51 % equities and equity alternatives and 49 % fixed income. The target asset allocation for the U.K. plans, which comprise approximately 78 % of non-U.S. plan assets, is 12 % equities and equity alternatives and 88 % fixed income. At December 31, 2024, the actual allocation for the U.K. plans was 12 % equities and equity alternatives and 88 % fixed income. The assets of the Company's defined benefit plans are diversified and are managed in accordance with applicable laws and with the goal of maximizing the plans' asset returns within acceptable risk parameters. The Company uses threshold-based portfolio re-balancing to ensure the actual portfolio remains consistent with target asset allocation ranges. | text | 49 | percentItemType | text: <entity> 49 </entity> <entity type> percentItemType </entity type> <context> The target asset allocation for the U.S. plans is 50 % equities and equity alternatives and 50 % fixed income. At December 31, 2024, the actual allocation for the U.S. plans was 51 % equities and equity alternatives and 49 % fixed income. The target asset allocation for the U.K. plans, which comprise approximately 78 % of non-U.S. plan assets, is 12 % equities and equity alternatives and 88 % fixed income. At December 31, 2024, the actual allocation for the U.K. plans was 12 % equities and equity alternatives and 88 % fixed income. The assets of the Company's defined benefit plans are diversified and are managed in accordance with applicable laws and with the goal of maximizing the plans' asset returns within acceptable risk parameters. The Company uses threshold-based portfolio re-balancing to ensure the actual portfolio remains consistent with target asset allocation ranges. </context> | us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations |
The target asset allocation for the U.S. plans is 50 % equities and equity alternatives and 50 % fixed income. At December 31, 2024, the actual allocation for the U.S. plans was 51 % equities and equity alternatives and 49 % fixed income. The target asset allocation for the U.K. plans, which comprise approximately 78 % of non-U.S. plan assets, is 12 % equities and equity alternatives and 88 % fixed income. At December 31, 2024, the actual allocation for the U.K. plans was 12 % equities and equity alternatives and 88 % fixed income. The assets of the Company's defined benefit plans are diversified and are managed in accordance with applicable laws and with the goal of maximizing the plans' asset returns within acceptable risk parameters. The Company uses threshold-based portfolio re-balancing to ensure the actual portfolio remains consistent with target asset allocation ranges. | text | 78 | percentItemType | text: <entity> 78 </entity> <entity type> percentItemType </entity type> <context> The target asset allocation for the U.S. plans is 50 % equities and equity alternatives and 50 % fixed income. At December 31, 2024, the actual allocation for the U.S. plans was 51 % equities and equity alternatives and 49 % fixed income. The target asset allocation for the U.K. plans, which comprise approximately 78 % of non-U.S. plan assets, is 12 % equities and equity alternatives and 88 % fixed income. At December 31, 2024, the actual allocation for the U.K. plans was 12 % equities and equity alternatives and 88 % fixed income. The assets of the Company's defined benefit plans are diversified and are managed in accordance with applicable laws and with the goal of maximizing the plans' asset returns within acceptable risk parameters. The Company uses threshold-based portfolio re-balancing to ensure the actual portfolio remains consistent with target asset allocation ranges. </context> | us-gaap:ConcentrationRiskPercentage1 |
The target asset allocation for the U.S. plans is 50 % equities and equity alternatives and 50 % fixed income. At December 31, 2024, the actual allocation for the U.S. plans was 51 % equities and equity alternatives and 49 % fixed income. The target asset allocation for the U.K. plans, which comprise approximately 78 % of non-U.S. plan assets, is 12 % equities and equity alternatives and 88 % fixed income. At December 31, 2024, the actual allocation for the U.K. plans was 12 % equities and equity alternatives and 88 % fixed income. The assets of the Company's defined benefit plans are diversified and are managed in accordance with applicable laws and with the goal of maximizing the plans' asset returns within acceptable risk parameters. The Company uses threshold-based portfolio re-balancing to ensure the actual portfolio remains consistent with target asset allocation ranges. | text | 12 | percentItemType | text: <entity> 12 </entity> <entity type> percentItemType </entity type> <context> The target asset allocation for the U.S. plans is 50 % equities and equity alternatives and 50 % fixed income. At December 31, 2024, the actual allocation for the U.S. plans was 51 % equities and equity alternatives and 49 % fixed income. The target asset allocation for the U.K. plans, which comprise approximately 78 % of non-U.S. plan assets, is 12 % equities and equity alternatives and 88 % fixed income. At December 31, 2024, the actual allocation for the U.K. plans was 12 % equities and equity alternatives and 88 % fixed income. The assets of the Company's defined benefit plans are diversified and are managed in accordance with applicable laws and with the goal of maximizing the plans' asset returns within acceptable risk parameters. The Company uses threshold-based portfolio re-balancing to ensure the actual portfolio remains consistent with target asset allocation ranges. </context> | us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage |
The target asset allocation for the U.S. plans is 50 % equities and equity alternatives and 50 % fixed income. At December 31, 2024, the actual allocation for the U.S. plans was 51 % equities and equity alternatives and 49 % fixed income. The target asset allocation for the U.K. plans, which comprise approximately 78 % of non-U.S. plan assets, is 12 % equities and equity alternatives and 88 % fixed income. At December 31, 2024, the actual allocation for the U.K. plans was 12 % equities and equity alternatives and 88 % fixed income. The assets of the Company's defined benefit plans are diversified and are managed in accordance with applicable laws and with the goal of maximizing the plans' asset returns within acceptable risk parameters. The Company uses threshold-based portfolio re-balancing to ensure the actual portfolio remains consistent with target asset allocation ranges. | text | 88 | percentItemType | text: <entity> 88 </entity> <entity type> percentItemType </entity type> <context> The target asset allocation for the U.S. plans is 50 % equities and equity alternatives and 50 % fixed income. At December 31, 2024, the actual allocation for the U.S. plans was 51 % equities and equity alternatives and 49 % fixed income. The target asset allocation for the U.K. plans, which comprise approximately 78 % of non-U.S. plan assets, is 12 % equities and equity alternatives and 88 % fixed income. At December 31, 2024, the actual allocation for the U.K. plans was 12 % equities and equity alternatives and 88 % fixed income. The assets of the Company's defined benefit plans are diversified and are managed in accordance with applicable laws and with the goal of maximizing the plans' asset returns within acceptable risk parameters. The Company uses threshold-based portfolio re-balancing to ensure the actual portfolio remains consistent with target asset allocation ranges. </context> | us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage |
The target asset allocation for the U.S. plans is 50 % equities and equity alternatives and 50 % fixed income. At December 31, 2024, the actual allocation for the U.S. plans was 51 % equities and equity alternatives and 49 % fixed income. The target asset allocation for the U.K. plans, which comprise approximately 78 % of non-U.S. plan assets, is 12 % equities and equity alternatives and 88 % fixed income. At December 31, 2024, the actual allocation for the U.K. plans was 12 % equities and equity alternatives and 88 % fixed income. The assets of the Company's defined benefit plans are diversified and are managed in accordance with applicable laws and with the goal of maximizing the plans' asset returns within acceptable risk parameters. The Company uses threshold-based portfolio re-balancing to ensure the actual portfolio remains consistent with target asset allocation ranges. | text | 12 | percentItemType | text: <entity> 12 </entity> <entity type> percentItemType </entity type> <context> The target asset allocation for the U.S. plans is 50 % equities and equity alternatives and 50 % fixed income. At December 31, 2024, the actual allocation for the U.S. plans was 51 % equities and equity alternatives and 49 % fixed income. The target asset allocation for the U.K. plans, which comprise approximately 78 % of non-U.S. plan assets, is 12 % equities and equity alternatives and 88 % fixed income. At December 31, 2024, the actual allocation for the U.K. plans was 12 % equities and equity alternatives and 88 % fixed income. The assets of the Company's defined benefit plans are diversified and are managed in accordance with applicable laws and with the goal of maximizing the plans' asset returns within acceptable risk parameters. The Company uses threshold-based portfolio re-balancing to ensure the actual portfolio remains consistent with target asset allocation ranges. </context> | us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations |
The target asset allocation for the U.S. plans is 50 % equities and equity alternatives and 50 % fixed income. At December 31, 2024, the actual allocation for the U.S. plans was 51 % equities and equity alternatives and 49 % fixed income. The target asset allocation for the U.K. plans, which comprise approximately 78 % of non-U.S. plan assets, is 12 % equities and equity alternatives and 88 % fixed income. At December 31, 2024, the actual allocation for the U.K. plans was 12 % equities and equity alternatives and 88 % fixed income. The assets of the Company's defined benefit plans are diversified and are managed in accordance with applicable laws and with the goal of maximizing the plans' asset returns within acceptable risk parameters. The Company uses threshold-based portfolio re-balancing to ensure the actual portfolio remains consistent with target asset allocation ranges. | text | 88 | percentItemType | text: <entity> 88 </entity> <entity type> percentItemType </entity type> <context> The target asset allocation for the U.S. plans is 50 % equities and equity alternatives and 50 % fixed income. At December 31, 2024, the actual allocation for the U.S. plans was 51 % equities and equity alternatives and 49 % fixed income. The target asset allocation for the U.K. plans, which comprise approximately 78 % of non-U.S. plan assets, is 12 % equities and equity alternatives and 88 % fixed income. At December 31, 2024, the actual allocation for the U.K. plans was 12 % equities and equity alternatives and 88 % fixed income. The assets of the Company's defined benefit plans are diversified and are managed in accordance with applicable laws and with the goal of maximizing the plans' asset returns within acceptable risk parameters. The Company uses threshold-based portfolio re-balancing to ensure the actual portfolio remains consistent with target asset allocation ranges. </context> | us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations |
The major categories of plan assets include equity securities, equity alternative investments, and fixed income securities. For the U.S. plans, the category ranges are 46 %- 54 % for both equities and equity alternatives, and for fixed income. For the U.K. plans, the category ranges are 9 %- 15 % for equities and equity alternatives, and 85 %- 91 % for fixed income. Asset allocation is frequently monitored and re-balancing actions are taken as appropriate. | text | 9 | percentItemType | text: <entity> 9 </entity> <entity type> percentItemType </entity type> <context> The major categories of plan assets include equity securities, equity alternative investments, and fixed income securities. For the U.S. plans, the category ranges are 46 %- 54 % for both equities and equity alternatives, and for fixed income. For the U.K. plans, the category ranges are 9 %- 15 % for equities and equity alternatives, and 85 %- 91 % for fixed income. Asset allocation is frequently monitored and re-balancing actions are taken as appropriate. </context> | us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage |
The major categories of plan assets include equity securities, equity alternative investments, and fixed income securities. For the U.S. plans, the category ranges are 46 %- 54 % for both equities and equity alternatives, and for fixed income. For the U.K. plans, the category ranges are 9 %- 15 % for equities and equity alternatives, and 85 %- 91 % for fixed income. Asset allocation is frequently monitored and re-balancing actions are taken as appropriate. | text | 15 | percentItemType | text: <entity> 15 </entity> <entity type> percentItemType </entity type> <context> The major categories of plan assets include equity securities, equity alternative investments, and fixed income securities. For the U.S. plans, the category ranges are 46 %- 54 % for both equities and equity alternatives, and for fixed income. For the U.K. plans, the category ranges are 9 %- 15 % for equities and equity alternatives, and 85 %- 91 % for fixed income. Asset allocation is frequently monitored and re-balancing actions are taken as appropriate. </context> | us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage |
The major categories of plan assets include equity securities, equity alternative investments, and fixed income securities. For the U.S. plans, the category ranges are 46 %- 54 % for both equities and equity alternatives, and for fixed income. For the U.K. plans, the category ranges are 9 %- 15 % for equities and equity alternatives, and 85 %- 91 % for fixed income. Asset allocation is frequently monitored and re-balancing actions are taken as appropriate. | text | 85 | percentItemType | text: <entity> 85 </entity> <entity type> percentItemType </entity type> <context> The major categories of plan assets include equity securities, equity alternative investments, and fixed income securities. For the U.S. plans, the category ranges are 46 %- 54 % for both equities and equity alternatives, and for fixed income. For the U.K. plans, the category ranges are 9 %- 15 % for equities and equity alternatives, and 85 %- 91 % for fixed income. Asset allocation is frequently monitored and re-balancing actions are taken as appropriate. </context> | us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage |
The major categories of plan assets include equity securities, equity alternative investments, and fixed income securities. For the U.S. plans, the category ranges are 46 %- 54 % for both equities and equity alternatives, and for fixed income. For the U.K. plans, the category ranges are 9 %- 15 % for equities and equity alternatives, and 85 %- 91 % for fixed income. Asset allocation is frequently monitored and re-balancing actions are taken as appropriate. | text | 91 | percentItemType | text: <entity> 91 </entity> <entity type> percentItemType </entity type> <context> The major categories of plan assets include equity securities, equity alternative investments, and fixed income securities. For the U.S. plans, the category ranges are 46 %- 54 % for both equities and equity alternatives, and for fixed income. For the U.K. plans, the category ranges are 9 %- 15 % for equities and equity alternatives, and 85 %- 91 % for fixed income. Asset allocation is frequently monitored and re-balancing actions are taken as appropriate. </context> | us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage |
, respectively, at December 31, 2024 and $ 4.7 billion and $ 4.2 billion, respectively, at December 31, 2023. | text | 4.7 | monetaryItemType | text: <entity> 4.7 </entity> <entity type> monetaryItemType </entity type> <context> , respectively, at December 31, 2024 and $ 4.7 billion and $ 4.2 billion, respectively, at December 31, 2023. </context> | us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation |
, respectively, at December 31, 2024 and $ 4.7 billion and $ 4.2 billion, respectively, at December 31, 2023. | text | 4.2 | monetaryItemType | text: <entity> 4.2 </entity> <entity type> monetaryItemType </entity type> <context> , respectively, at December 31, 2024 and $ 4.7 billion and $ 4.2 billion, respectively, at December 31, 2023. </context> | us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets |
The Company expects to contribute approximately $ 35 million to its non-qualified U.S. plans in 2025. The Company’s policy for funding its tax-qualified defined benefit retirement plans is to contribute amounts at least sufficient to meet the funding requirements set forth in the U.S., and applicable foreign law. | text | 35 | monetaryItemType | text: <entity> 35 </entity> <entity type> monetaryItemType </entity type> <context> The Company expects to contribute approximately $ 35 million to its non-qualified U.S. plans in 2025. The Company’s policy for funding its tax-qualified defined benefit retirement plans is to contribute amounts at least sufficient to meet the funding requirements set forth in the U.S., and applicable foreign law. </context> | us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear |
In 2025, the Company is expected to be required to make contributions totaling $ 2 million to its U.S. qualified plans. | text | 2 | monetaryItemType | text: <entity> 2 </entity> <entity type> monetaryItemType </entity type> <context> In 2025, the Company is expected to be required to make contributions totaling $ 2 million to its U.S. qualified plans. </context> | us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear |
, respectively, at December 31, 2024 and $ 427 million and $ 210 million, respectively, at December 31, 2023. | text | 427 | monetaryItemType | text: <entity> 427 </entity> <entity type> monetaryItemType </entity type> <context> , respectively, at December 31, 2024 and $ 427 million and $ 210 million, respectively, at December 31, 2023. </context> | us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation |
, respectively, at December 31, 2024 and $ 427 million and $ 210 million, respectively, at December 31, 2023. | text | 210 | monetaryItemType | text: <entity> 210 </entity> <entity type> monetaryItemType </entity type> <context> , respectively, at December 31, 2024 and $ 427 million and $ 210 million, respectively, at December 31, 2023. </context> | us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets |
, respectively, at December 31, 2024 and $ 1.3 billion and $ 1.0 billion, respectively, at December 31, 2023. | text | 1.3 | monetaryItemType | text: <entity> 1.3 </entity> <entity type> monetaryItemType </entity type> <context> , respectively, at December 31, 2024 and $ 1.3 billion and $ 1.0 billion, respectively, at December 31, 2023. </context> | us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation |
, respectively, at December 31, 2024 and $ 1.3 billion and $ 1.0 billion, respectively, at December 31, 2023. | text | 1.0 | monetaryItemType | text: <entity> 1.0 </entity> <entity type> monetaryItemType </entity type> <context> , respectively, at December 31, 2024 and $ 1.3 billion and $ 1.0 billion, respectively, at December 31, 2023. </context> | us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets |
Pension Scheme was merged into the MMC U.K. Pension Fund with a new segregated JLT section created. The Company made deficit contributions of $ 20 million to the JLT section in 2024 and is no t required to make any deficit contributions to the JLT section in | text | 20 | monetaryItemType | text: <entity> 20 </entity> <entity type> monetaryItemType </entity type> <context> Pension Scheme was merged into the MMC U.K. Pension Fund with a new segregated JLT section created. The Company made deficit contributions of $ 20 million to the JLT section in 2024 and is no t required to make any deficit contributions to the JLT section in </context> | us-gaap:DefinedBenefitPlanContributionsByEmployer |
Pension Scheme was merged into the MMC U.K. Pension Fund with a new segregated JLT section created. The Company made deficit contributions of $ 20 million to the JLT section in 2024 and is no t required to make any deficit contributions to the JLT section in | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> Pension Scheme was merged into the MMC U.K. Pension Fund with a new segregated JLT section created. The Company made deficit contributions of $ 20 million to the JLT section in 2024 and is no t required to make any deficit contributions to the JLT section in </context> | us-gaap:DefinedBenefitPlanContributionsByEmployer |
For the MMC U.K. Pension Fund, excluding the JLT section, an agreement was reached with the trustee in the fourth quarter of 2022 based on the surplus funding position at December 31, 2021. In accordance with the agreement, no deficit funding is required at the earliest until 2026. The funding level will be re-assessed during 2025, as part of the December 31, 2024 actuarial valuation to determine if contributions are required in 2026. In December 2022, the Company renewed its agreement to support annual deficit contributions that may be required by the U.K. operating companies under certain circumstances, up to £ 450 million (or $ 566 million) over a seven-year period. This is part of an agreement which gives the Company greater influence over asset allocation and overall investment decisions. | text | 450 | monetaryItemType | text: <entity> 450 </entity> <entity type> monetaryItemType </entity type> <context> For the MMC U.K. Pension Fund, excluding the JLT section, an agreement was reached with the trustee in the fourth quarter of 2022 based on the surplus funding position at December 31, 2021. In accordance with the agreement, no deficit funding is required at the earliest until 2026. The funding level will be re-assessed during 2025, as part of the December 31, 2024 actuarial valuation to determine if contributions are required in 2026. In December 2022, the Company renewed its agreement to support annual deficit contributions that may be required by the U.K. operating companies under certain circumstances, up to £ 450 million (or $ 566 million) over a seven-year period. This is part of an agreement which gives the Company greater influence over asset allocation and overall investment decisions. </context> | us-gaap:GuaranteeObligationsMaximumExposure |
For the MMC U.K. Pension Fund, excluding the JLT section, an agreement was reached with the trustee in the fourth quarter of 2022 based on the surplus funding position at December 31, 2021. In accordance with the agreement, no deficit funding is required at the earliest until 2026. The funding level will be re-assessed during 2025, as part of the December 31, 2024 actuarial valuation to determine if contributions are required in 2026. In December 2022, the Company renewed its agreement to support annual deficit contributions that may be required by the U.K. operating companies under certain circumstances, up to £ 450 million (or $ 566 million) over a seven-year period. This is part of an agreement which gives the Company greater influence over asset allocation and overall investment decisions. | text | 566 | monetaryItemType | text: <entity> 566 </entity> <entity type> monetaryItemType </entity type> <context> For the MMC U.K. Pension Fund, excluding the JLT section, an agreement was reached with the trustee in the fourth quarter of 2022 based on the surplus funding position at December 31, 2021. In accordance with the agreement, no deficit funding is required at the earliest until 2026. The funding level will be re-assessed during 2025, as part of the December 31, 2024 actuarial valuation to determine if contributions are required in 2026. In December 2022, the Company renewed its agreement to support annual deficit contributions that may be required by the U.K. operating companies under certain circumstances, up to £ 450 million (or $ 566 million) over a seven-year period. This is part of an agreement which gives the Company greater influence over asset allocation and overall investment decisions. </context> | us-gaap:GuaranteeObligationsMaximumExposure |
The Company maintains certain defined contribution plans for its employees, including the Marsh & McLennan Companies 401(k) Savings & Investment Plan ("MMC 401(k) Plan") and the Marsh & McLennan Agency Savings and Investment Plan (collectively, the "401(k) Plans"), that are qualified under U.S. tax laws. For the 401(k) Plans, eligible employees may contribute a percentage of their base salary, subject to certain limitations, and the Company matches a fixed portion of the employees’ contributions. In addition, the Company also amended the MMC 401(k) Plan for most of its U.S. employees to add an automatic Company contribution equal to 4 % of eligible base pay beginning on January 1, 2017. The 401(k) Plans contain an Employee Stock Ownership Plan feature under U.S. tax law. | text | 4 | percentItemType | text: <entity> 4 </entity> <entity type> percentItemType </entity type> <context> The Company maintains certain defined contribution plans for its employees, including the Marsh & McLennan Companies 401(k) Savings & Investment Plan ("MMC 401(k) Plan") and the Marsh & McLennan Agency Savings and Investment Plan (collectively, the "401(k) Plans"), that are qualified under U.S. tax laws. For the 401(k) Plans, eligible employees may contribute a percentage of their base salary, subject to certain limitations, and the Company matches a fixed portion of the employees’ contributions. In addition, the Company also amended the MMC 401(k) Plan for most of its U.S. employees to add an automatic Company contribution equal to 4 % of eligible base pay beginning on January 1, 2017. The 401(k) Plans contain an Employee Stock Ownership Plan feature under U.S. tax law. </context> | us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent |
in 2024, $ 173 million in 2023 and $ 161 million in 2022. In addition, the Company has significant defined contribution plans in the U.K. Effective August 1, 2014, a newly formed defined contribution plan replaced the existing defined contribution and defined benefit plans with regard to future service. In addition, the Company assumed responsibility for the defined contribution section of the JLT U.K. plan. Members of the JLT U.K. plan defined contribution section transferred to the MMC U.K. Pension Fund defined contribution section in 2021. The cost of the U.K. defined contribution plan was | text | 173 | monetaryItemType | text: <entity> 173 </entity> <entity type> monetaryItemType </entity type> <context> in 2024, $ 173 million in 2023 and $ 161 million in 2022. In addition, the Company has significant defined contribution plans in the U.K. Effective August 1, 2014, a newly formed defined contribution plan replaced the existing defined contribution and defined benefit plans with regard to future service. In addition, the Company assumed responsibility for the defined contribution section of the JLT U.K. plan. Members of the JLT U.K. plan defined contribution section transferred to the MMC U.K. Pension Fund defined contribution section in 2021. The cost of the U.K. defined contribution plan was </context> | us-gaap:DefinedContributionPlanCostRecognized |
in 2024, $ 173 million in 2023 and $ 161 million in 2022. In addition, the Company has significant defined contribution plans in the U.K. Effective August 1, 2014, a newly formed defined contribution plan replaced the existing defined contribution and defined benefit plans with regard to future service. In addition, the Company assumed responsibility for the defined contribution section of the JLT U.K. plan. Members of the JLT U.K. plan defined contribution section transferred to the MMC U.K. Pension Fund defined contribution section in 2021. The cost of the U.K. defined contribution plan was | text | 161 | monetaryItemType | text: <entity> 161 </entity> <entity type> monetaryItemType </entity type> <context> in 2024, $ 173 million in 2023 and $ 161 million in 2022. In addition, the Company has significant defined contribution plans in the U.K. Effective August 1, 2014, a newly formed defined contribution plan replaced the existing defined contribution and defined benefit plans with regard to future service. In addition, the Company assumed responsibility for the defined contribution section of the JLT U.K. plan. Members of the JLT U.K. plan defined contribution section transferred to the MMC U.K. Pension Fund defined contribution section in 2021. The cost of the U.K. defined contribution plan was </context> | us-gaap:DefinedContributionPlanCostRecognized |
, $ 158 million and $ 140 million | text | 158 | monetaryItemType | text: <entity> 158 </entity> <entity type> monetaryItemType </entity type> <context> , $ 158 million and $ 140 million </context> | us-gaap:DefinedContributionPlanCostRecognized |
, $ 158 million and $ 140 million | text | 140 | monetaryItemType | text: <entity> 140 </entity> <entity type> monetaryItemType </entity type> <context> , $ 158 million and $ 140 million </context> | us-gaap:DefinedContributionPlanCostRecognized |
The types of awards permitted under the 2020 Plan include stock options, restricted stock units payable in Company common stock or cash, and other stock-based awards. Performance-based restricted stock units are referred to as performance stock units. The 2020 Plan contains a provision which, in the event of a change in control of the Company, may accelerate the vesting of awards. This provision requires both a change in control of the Company and a subsequent specified termination of employment for vesting to be accelerated. There are 20 million shares approved for issuance under the 2020 Plan. The total number of shares issued in connection with full-value awards may not exceed 12.5 million shares. Full-value awards include awards such as restricted stock units and performance stock units but exclude stock options. | text | 20 | sharesItemType | text: <entity> 20 </entity> <entity type> sharesItemType </entity type> <context> The types of awards permitted under the 2020 Plan include stock options, restricted stock units payable in Company common stock or cash, and other stock-based awards. Performance-based restricted stock units are referred to as performance stock units. The 2020 Plan contains a provision which, in the event of a change in control of the Company, may accelerate the vesting of awards. This provision requires both a change in control of the Company and a subsequent specified termination of employment for vesting to be accelerated. There are 20 million shares approved for issuance under the 2020 Plan. The total number of shares issued in connection with full-value awards may not exceed 12.5 million shares. Full-value awards include awards such as restricted stock units and performance stock units but exclude stock options. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
The types of awards permitted under the 2020 Plan include stock options, restricted stock units payable in Company common stock or cash, and other stock-based awards. Performance-based restricted stock units are referred to as performance stock units. The 2020 Plan contains a provision which, in the event of a change in control of the Company, may accelerate the vesting of awards. This provision requires both a change in control of the Company and a subsequent specified termination of employment for vesting to be accelerated. There are 20 million shares approved for issuance under the 2020 Plan. The total number of shares issued in connection with full-value awards may not exceed 12.5 million shares. Full-value awards include awards such as restricted stock units and performance stock units but exclude stock options. | text | 12.5 | sharesItemType | text: <entity> 12.5 </entity> <entity type> sharesItemType </entity type> <context> The types of awards permitted under the 2020 Plan include stock options, restricted stock units payable in Company common stock or cash, and other stock-based awards. Performance-based restricted stock units are referred to as performance stock units. The 2020 Plan contains a provision which, in the event of a change in control of the Company, may accelerate the vesting of awards. This provision requires both a change in control of the Company and a subsequent specified termination of employment for vesting to be accelerated. There are 20 million shares approved for issuance under the 2020 Plan. The total number of shares issued in connection with full-value awards may not exceed 12.5 million shares. Full-value awards include awards such as restricted stock units and performance stock units but exclude stock options. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
The Company currently grants non-qualified stock options under the 2020 Plan. The Compensation Committee determines when the options vest and may be exercised and under what terms the options are forfeited. Options are generally granted with an exercise price equal to the market value of the Company's common stock on the date of grant. Option awards generally vest 25 % per year and have a contractual term of 10 years. | text | 25 | percentItemType | text: <entity> 25 </entity> <entity type> percentItemType </entity type> <context> The Company currently grants non-qualified stock options under the 2020 Plan. The Compensation Committee determines when the options vest and may be exercised and under what terms the options are forfeited. Options are generally granted with an exercise price equal to the market value of the Company's common stock on the date of grant. Option awards generally vest 25 % per year and have a contractual term of 10 years. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage |
, $ 41.92 and $ 31.38 , respectively. The total intrinsic value of options exercised during the same periods was | text | 41.92 | perShareItemType | text: <entity> 41.92 </entity> <entity type> perShareItemType </entity type> <context> , $ 41.92 and $ 31.38 , respectively. The total intrinsic value of options exercised during the same periods was </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
, $ 41.92 and $ 31.38 , respectively. The total intrinsic value of options exercised during the same periods was | text | 31.38 | perShareItemType | text: <entity> 31.38 </entity> <entity type> perShareItemType </entity type> <context> , $ 41.92 and $ 31.38 , respectively. The total intrinsic value of options exercised during the same periods was </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
, $ 164 million and $ 56 million, respectively. | text | 164 | monetaryItemType | text: <entity> 164 </entity> <entity type> monetaryItemType </entity type> <context> , $ 164 million and $ 56 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
, $ 164 million and $ 56 million, respectively. | text | 56 | monetaryItemType | text: <entity> 56 </entity> <entity type> monetaryItemType </entity type> <context> , $ 164 million and $ 56 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
$ 36.7 million of unrecognized compensation cost related to the Company's option awards. The weighted-average period over which that cost is expected to be recognized is approximately 1.2 years. Cash received from the exercise of stock options in 2024, 2023 and 2022 was | text | 36.7 | monetaryItemType | text: <entity> 36.7 </entity> <entity type> monetaryItemType </entity type> <context> $ 36.7 million of unrecognized compensation cost related to the Company's option awards. The weighted-average period over which that cost is expected to be recognized is approximately 1.2 years. Cash received from the exercise of stock options in 2024, 2023 and 2022 was </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
, $ 116 million and $ 50 million, respectively. | text | 116 | monetaryItemType | text: <entity> 116 </entity> <entity type> monetaryItemType </entity type> <context> , $ 116 million and $ 50 million, respectively. </context> | us-gaap:ProceedsFromStockOptionsExercised |
, $ 116 million and $ 50 million, respectively. | text | 50 | monetaryItemType | text: <entity> 50 </entity> <entity type> monetaryItemType </entity type> <context> , $ 116 million and $ 50 million, respectively. </context> | us-gaap:ProceedsFromStockOptionsExercised |
The weighted-average grant-date fair value of the Company's RSU awards granted in 2023 and 2022 was $ 165.05 and $ 152.34 , respectively. The weighted-average grant-date fair value of the Company's PSU awards granted in 2023 and 2022 was $ 170.80 and $ 151.00 , respectively. The total fair value of the shares distributed in 2024, 2023 and 2022 in connection with the Company's non-option equity awards was $ 483 million | text | 165.05 | perShareItemType | text: <entity> 165.05 </entity> <entity type> perShareItemType </entity type> <context> The weighted-average grant-date fair value of the Company's RSU awards granted in 2023 and 2022 was $ 165.05 and $ 152.34 , respectively. The weighted-average grant-date fair value of the Company's PSU awards granted in 2023 and 2022 was $ 170.80 and $ 151.00 , respectively. The total fair value of the shares distributed in 2024, 2023 and 2022 in connection with the Company's non-option equity awards was $ 483 million </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The weighted-average grant-date fair value of the Company's RSU awards granted in 2023 and 2022 was $ 165.05 and $ 152.34 , respectively. The weighted-average grant-date fair value of the Company's PSU awards granted in 2023 and 2022 was $ 170.80 and $ 151.00 , respectively. The total fair value of the shares distributed in 2024, 2023 and 2022 in connection with the Company's non-option equity awards was $ 483 million | text | 152.34 | perShareItemType | text: <entity> 152.34 </entity> <entity type> perShareItemType </entity type> <context> The weighted-average grant-date fair value of the Company's RSU awards granted in 2023 and 2022 was $ 165.05 and $ 152.34 , respectively. The weighted-average grant-date fair value of the Company's PSU awards granted in 2023 and 2022 was $ 170.80 and $ 151.00 , respectively. The total fair value of the shares distributed in 2024, 2023 and 2022 in connection with the Company's non-option equity awards was $ 483 million </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The weighted-average grant-date fair value of the Company's RSU awards granted in 2023 and 2022 was $ 165.05 and $ 152.34 , respectively. The weighted-average grant-date fair value of the Company's PSU awards granted in 2023 and 2022 was $ 170.80 and $ 151.00 , respectively. The total fair value of the shares distributed in 2024, 2023 and 2022 in connection with the Company's non-option equity awards was $ 483 million | text | 170.80 | perShareItemType | text: <entity> 170.80 </entity> <entity type> perShareItemType </entity type> <context> The weighted-average grant-date fair value of the Company's RSU awards granted in 2023 and 2022 was $ 165.05 and $ 152.34 , respectively. The weighted-average grant-date fair value of the Company's PSU awards granted in 2023 and 2022 was $ 170.80 and $ 151.00 , respectively. The total fair value of the shares distributed in 2024, 2023 and 2022 in connection with the Company's non-option equity awards was $ 483 million </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The weighted-average grant-date fair value of the Company's RSU awards granted in 2023 and 2022 was $ 165.05 and $ 152.34 , respectively. The weighted-average grant-date fair value of the Company's PSU awards granted in 2023 and 2022 was $ 170.80 and $ 151.00 , respectively. The total fair value of the shares distributed in 2024, 2023 and 2022 in connection with the Company's non-option equity awards was $ 483 million | text | 151.00 | perShareItemType | text: <entity> 151.00 </entity> <entity type> perShareItemType </entity type> <context> The weighted-average grant-date fair value of the Company's RSU awards granted in 2023 and 2022 was $ 165.05 and $ 152.34 , respectively. The weighted-average grant-date fair value of the Company's PSU awards granted in 2023 and 2022 was $ 170.80 and $ 151.00 , respectively. The total fair value of the shares distributed in 2024, 2023 and 2022 in connection with the Company's non-option equity awards was $ 483 million </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
In May 1999, the Company's stockholders approved an employee stock purchase plan (the "1999 Plan") to replace the 1994 Employee Stock Purchase Plan (the "1994 Plan"), which terminated on September 30, 1999, following its fifth annual offering. In accordance with the current terms of the 1999 Plan, shares are purchased 4 times during the plan year at a price that is 95 % of the average market price on each quarterly purchase date. In accordance with the 1999 Plan, after including the available remaining unused shares in the 1994 Plan and reducing the shares available by 10,000,000 consistent with the Company's Board of Directors' action in March 2007 and the addition of 4,750,000 shares due to | text | 95 | percentItemType | text: <entity> 95 </entity> <entity type> percentItemType </entity type> <context> In May 1999, the Company's stockholders approved an employee stock purchase plan (the "1999 Plan") to replace the 1994 Employee Stock Purchase Plan (the "1994 Plan"), which terminated on September 30, 1999, following its fifth annual offering. In accordance with the current terms of the 1999 Plan, shares are purchased 4 times during the plan year at a price that is 95 % of the average market price on each quarterly purchase date. In accordance with the 1999 Plan, after including the available remaining unused shares in the 1994 Plan and reducing the shares available by 10,000,000 consistent with the Company's Board of Directors' action in March 2007 and the addition of 4,750,000 shares due to </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent |
In May 1999, the Company's stockholders approved an employee stock purchase plan (the "1999 Plan") to replace the 1994 Employee Stock Purchase Plan (the "1994 Plan"), which terminated on September 30, 1999, following its fifth annual offering. In accordance with the current terms of the 1999 Plan, shares are purchased 4 times during the plan year at a price that is 95 % of the average market price on each quarterly purchase date. In accordance with the 1999 Plan, after including the available remaining unused shares in the 1994 Plan and reducing the shares available by 10,000,000 consistent with the Company's Board of Directors' action in March 2007 and the addition of 4,750,000 shares due to | text | 4750000 | sharesItemType | text: <entity> 4750000 </entity> <entity type> sharesItemType </entity type> <context> In May 1999, the Company's stockholders approved an employee stock purchase plan (the "1999 Plan") to replace the 1994 Employee Stock Purchase Plan (the "1994 Plan"), which terminated on September 30, 1999, following its fifth annual offering. In accordance with the current terms of the 1999 Plan, shares are purchased 4 times during the plan year at a price that is 95 % of the average market price on each quarterly purchase date. In accordance with the 1999 Plan, after including the available remaining unused shares in the 1994 Plan and reducing the shares available by 10,000,000 consistent with the Company's Board of Directors' action in March 2007 and the addition of 4,750,000 shares due to </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized |
shares in 2024 and at December 31, 2024, 3,547,195 shares were available for issuance for the 1999 Plan. | text | 3547195 | sharesItemType | text: <entity> 3547195 </entity> <entity type> sharesItemType </entity type> <context> shares in 2024 and at December 31, 2024, 3,547,195 shares were available for issuance for the 1999 Plan. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant |
The Company has investments in certain private equity funds as well as in public and private companies that are accounted for using the equity method of accounting. The carrying value of these investments was $ 257 million and $ 266 million at December 31, 2024 and 2023, respectively. | text | 257 | monetaryItemType | text: <entity> 257 </entity> <entity type> monetaryItemType </entity type> <context> The Company has investments in certain private equity funds as well as in public and private companies that are accounted for using the equity method of accounting. The carrying value of these investments was $ 257 million and $ 266 million at December 31, 2024 and 2023, respectively. </context> | us-gaap:EquityMethodInvestments |
The Company has investments in certain private equity funds as well as in public and private companies that are accounted for using the equity method of accounting. The carrying value of these investments was $ 257 million and $ 266 million at December 31, 2024 and 2023, respectively. | text | 266 | monetaryItemType | text: <entity> 266 </entity> <entity type> monetaryItemType </entity type> <context> The Company has investments in certain private equity funds as well as in public and private companies that are accounted for using the equity method of accounting. The carrying value of these investments was $ 257 million and $ 266 million at December 31, 2024 and 2023, respectively. </context> | us-gaap:EquityMethodInvestments |
The Company's investments in private equity funds were $ 182 million and $ 203 million at December 31, 2024 and 2023, respectively. The carrying values of these private equity investments approximates fair value. The underlying private equity funds follow investment company accounting, where investments within the fund are carried at fair value. The Company records in earnings its proportionate share of the change in fair value of the funds in the investment income line in the consolidated statements of income. These investments are included in other assets in the consolidated balance sheets. The Company recorded net investment income from these investments | text | 182 | monetaryItemType | text: <entity> 182 </entity> <entity type> monetaryItemType </entity type> <context> The Company's investments in private equity funds were $ 182 million and $ 203 million at December 31, 2024 and 2023, respectively. The carrying values of these private equity investments approximates fair value. The underlying private equity funds follow investment company accounting, where investments within the fund are carried at fair value. The Company records in earnings its proportionate share of the change in fair value of the funds in the investment income line in the consolidated statements of income. These investments are included in other assets in the consolidated balance sheets. The Company recorded net investment income from these investments </context> | us-gaap:EquityMethodInvestments |
The Company's investments in private equity funds were $ 182 million and $ 203 million at December 31, 2024 and 2023, respectively. The carrying values of these private equity investments approximates fair value. The underlying private equity funds follow investment company accounting, where investments within the fund are carried at fair value. The Company records in earnings its proportionate share of the change in fair value of the funds in the investment income line in the consolidated statements of income. These investments are included in other assets in the consolidated balance sheets. The Company recorded net investment income from these investments | text | 203 | monetaryItemType | text: <entity> 203 </entity> <entity type> monetaryItemType </entity type> <context> The Company's investments in private equity funds were $ 182 million and $ 203 million at December 31, 2024 and 2023, respectively. The carrying values of these private equity investments approximates fair value. The underlying private equity funds follow investment company accounting, where investments within the fund are carried at fair value. The Company records in earnings its proportionate share of the change in fair value of the funds in the investment income line in the consolidated statements of income. These investments are included in other assets in the consolidated balance sheets. The Company recorded net investment income from these investments </context> | us-gaap:EquityMethodInvestments |
$ 4 million, $ 7 million and $ 18 million in 2024, 2023 and 2022, respectively. | text | 4 | monetaryItemType | text: <entity> 4 </entity> <entity type> monetaryItemType </entity type> <context> $ 4 million, $ 7 million and $ 18 million in 2024, 2023 and 2022, respectively. </context> | us-gaap:IncomeLossFromEquityMethodInvestments |
$ 4 million, $ 7 million and $ 18 million in 2024, 2023 and 2022, respectively. | text | 7 | monetaryItemType | text: <entity> 7 </entity> <entity type> monetaryItemType </entity type> <context> $ 4 million, $ 7 million and $ 18 million in 2024, 2023 and 2022, respectively. </context> | us-gaap:IncomeLossFromEquityMethodInvestments |
$ 4 million, $ 7 million and $ 18 million in 2024, 2023 and 2022, respectively. | text | 18 | monetaryItemType | text: <entity> 18 </entity> <entity type> monetaryItemType </entity type> <context> $ 4 million, $ 7 million and $ 18 million in 2024, 2023 and 2022, respectively. </context> | us-gaap:IncomeLossFromEquityMethodInvestments |
The Company has investments in private insurance brokerage and consulting companies with a carrying value of $ 75 million and $ 63 million at December 31, 2024 and 2023, respectively. These investments are accounted for using the equity method of accounting, the results of which are included in revenue in the consolidated statements of income and the carrying value of which is included in other assets in the consolidated balance sheets. The Company records its share of income or loss on its equity method investments, some of which are on a one quarter lag basis. | text | 75 | monetaryItemType | text: <entity> 75 </entity> <entity type> monetaryItemType </entity type> <context> The Company has investments in private insurance brokerage and consulting companies with a carrying value of $ 75 million and $ 63 million at December 31, 2024 and 2023, respectively. These investments are accounted for using the equity method of accounting, the results of which are included in revenue in the consolidated statements of income and the carrying value of which is included in other assets in the consolidated balance sheets. The Company records its share of income or loss on its equity method investments, some of which are on a one quarter lag basis. </context> | us-gaap:EquityMethodInvestments |
The Company has investments in private insurance brokerage and consulting companies with a carrying value of $ 75 million and $ 63 million at December 31, 2024 and 2023, respectively. These investments are accounted for using the equity method of accounting, the results of which are included in revenue in the consolidated statements of income and the carrying value of which is included in other assets in the consolidated balance sheets. The Company records its share of income or loss on its equity method investments, some of which are on a one quarter lag basis. | text | 63 | monetaryItemType | text: <entity> 63 </entity> <entity type> monetaryItemType </entity type> <context> The Company has investments in private insurance brokerage and consulting companies with a carrying value of $ 75 million and $ 63 million at December 31, 2024 and 2023, respectively. These investments are accounted for using the equity method of accounting, the results of which are included in revenue in the consolidated statements of income and the carrying value of which is included in other assets in the consolidated balance sheets. The Company records its share of income or loss on its equity method investments, some of which are on a one quarter lag basis. </context> | us-gaap:EquityMethodInvestments |
The Company held certain equity investments with readily determinable market values at December 31, 2024 and 2023, of $ 19 million and $ 16 million, respectively. The Company recorded a mark-to-market gain on these investments of $ 1 million, a mark-to-market loss of | text | 19 | monetaryItemType | text: <entity> 19 </entity> <entity type> monetaryItemType </entity type> <context> The Company held certain equity investments with readily determinable market values at December 31, 2024 and 2023, of $ 19 million and $ 16 million, respectively. The Company recorded a mark-to-market gain on these investments of $ 1 million, a mark-to-market loss of </context> | us-gaap:EquitySecuritiesFvNi |
The Company held certain equity investments with readily determinable market values at December 31, 2024 and 2023, of $ 19 million and $ 16 million, respectively. The Company recorded a mark-to-market gain on these investments of $ 1 million, a mark-to-market loss of | text | 16 | monetaryItemType | text: <entity> 16 </entity> <entity type> monetaryItemType </entity type> <context> The Company held certain equity investments with readily determinable market values at December 31, 2024 and 2023, of $ 19 million and $ 16 million, respectively. The Company recorded a mark-to-market gain on these investments of $ 1 million, a mark-to-market loss of </context> | us-gaap:EquitySecuritiesFvNi |
The Company held certain equity investments with readily determinable market values at December 31, 2024 and 2023, of $ 19 million and $ 16 million, respectively. The Company recorded a mark-to-market gain on these investments of $ 1 million, a mark-to-market loss of | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> The Company held certain equity investments with readily determinable market values at December 31, 2024 and 2023, of $ 19 million and $ 16 million, respectively. The Company recorded a mark-to-market gain on these investments of $ 1 million, a mark-to-market loss of </context> | us-gaap:EquitySecuritiesFvNiGainLoss |
$ 1 million and mark-to-market gains of $ 11 million in | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> $ 1 million and mark-to-market gains of $ 11 million in </context> | us-gaap:EquitySecuritiesFvNiGainLoss |
$ 1 million and mark-to-market gains of $ 11 million in | text | 11 | monetaryItemType | text: <entity> 11 </entity> <entity type> monetaryItemType </entity type> <context> $ 1 million and mark-to-market gains of $ 11 million in </context> | us-gaap:EquitySecuritiesFvNiGainLoss |
and $ 20 million at December 31, 2024 and 2023, respectively. | text | 20 | monetaryItemType | text: <entity> 20 </entity> <entity type> monetaryItemType </entity type> <context> and $ 20 million at December 31, 2024 and 2023, respectively. </context> | us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount |
In 2023, the Company recorded a net loss of $ 1 million on these investments. | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> In 2023, the Company recorded a net loss of $ 1 million on these investments. </context> | us-gaap:EquitySecuritiesFvNiGainLoss |
in a unit trust fund acquired in the current year. In 2024, the Company recorded mark-to-market gains from this investment of $ 7 million. | text | 7 | monetaryItemType | text: <entity> 7 </entity> <entity type> monetaryItemType </entity type> <context> in a unit trust fund acquired in the current year. In 2024, the Company recorded mark-to-market gains from this investment of $ 7 million. </context> | us-gaap:GainLossOnInvestments |
The Company has investments in various subsidiaries with Euro functional currencies. As a result, the Company is exposed to the risk of fluctuations between the Euro and U.S. dollar exchange rates. As part of its risk management program, the Company designated its € 1.1 billion senior note debt instruments ("Euro notes") as a net investment hedge (the "hedge") of its Euro denominated subsidiaries. The hedge effectiveness is re-assessed each quarter to confirm that the designated equity balance at the beginning of each period continues to equal or exceed 80 % of the outstanding balance of the Euro debt instrument and that all the critical terms of the hedging instrument and the hedged net investment continue to match. If the hedge is highly effective, the change in the debt balance related to foreign exchange fluctuations is recorded in accumulated other comprehensive loss in the consolidated balance sheets. | text | 1.1 | monetaryItemType | text: <entity> 1.1 </entity> <entity type> monetaryItemType </entity type> <context> The Company has investments in various subsidiaries with Euro functional currencies. As a result, the Company is exposed to the risk of fluctuations between the Euro and U.S. dollar exchange rates. As part of its risk management program, the Company designated its € 1.1 billion senior note debt instruments ("Euro notes") as a net investment hedge (the "hedge") of its Euro denominated subsidiaries. The hedge effectiveness is re-assessed each quarter to confirm that the designated equity balance at the beginning of each period continues to equal or exceed 80 % of the outstanding balance of the Euro debt instrument and that all the critical terms of the hedging instrument and the hedged net investment continue to match. If the hedge is highly effective, the change in the debt balance related to foreign exchange fluctuations is recorded in accumulated other comprehensive loss in the consolidated balance sheets. </context> | us-gaap:DerivativeNotionalAmount |
otes decreased by $ 75 million in | text | 75 | monetaryItemType | text: <entity> 75 </entity> <entity type> monetaryItemType </entity type> <context> otes decreased by $ 75 million in </context> | us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax |
and 2023, the Company determined that a total of $ 15 million and $ 27 million, respectively, of the ROU assets were impaired and recorded a charge to the consolidated statements of income with an offsetting reduction to the ROU assets. | text | 15 | monetaryItemType | text: <entity> 15 </entity> <entity type> monetaryItemType </entity type> <context> and 2023, the Company determined that a total of $ 15 million and $ 27 million, respectively, of the ROU assets were impaired and recorded a charge to the consolidated statements of income with an offsetting reduction to the ROU assets. </context> | us-gaap:OperatingLeaseImpairmentLoss |
and 2023, the Company determined that a total of $ 15 million and $ 27 million, respectively, of the ROU assets were impaired and recorded a charge to the consolidated statements of income with an offsetting reduction to the ROU assets. | text | 27 | monetaryItemType | text: <entity> 27 </entity> <entity type> monetaryItemType </entity type> <context> and 2023, the Company determined that a total of $ 15 million and $ 27 million, respectively, of the ROU assets were impaired and recorded a charge to the consolidated statements of income with an offsetting reduction to the ROU assets. </context> | us-gaap:OperatingLeaseImpairmentLoss |
At December 31, 2024, the Company did no t have any additional operating real estate leases that had not yet com | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024, the Company did no t have any additional operating real estate leases that had not yet com </context> | us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount |
In November 2023, the Company increased its short-term commercial paper financing program (the "Program") to $ 3.5 billion from $ 2.8 billion. The Company did not have any commercial paper outstanding at December 31, 2024 and 2023. | text | 3.5 | monetaryItemType | text: <entity> 3.5 </entity> <entity type> monetaryItemType </entity type> <context> In November 2023, the Company increased its short-term commercial paper financing program (the "Program") to $ 3.5 billion from $ 2.8 billion. The Company did not have any commercial paper outstanding at December 31, 2024 and 2023. </context> | us-gaap:ShortTermBorrowings |
In November 2023, the Company increased its short-term commercial paper financing program (the "Program") to $ 3.5 billion from $ 2.8 billion. The Company did not have any commercial paper outstanding at December 31, 2024 and 2023. | text | 2.8 | monetaryItemType | text: <entity> 2.8 </entity> <entity type> monetaryItemType </entity type> <context> In November 2023, the Company increased its short-term commercial paper financing program (the "Program") to $ 3.5 billion from $ 2.8 billion. The Company did not have any commercial paper outstanding at December 31, 2024 and 2023. </context> | us-gaap:ShortTermBorrowings |
In October 2023, the Company increased its multi-currency unsecured five-year revolving credit facility (the "Credit Facility") capacity to $ 3.5 billion from $ 2.8 billion and extended the expiration to October 2028. The interest rate on the Credit Facility was initially based on LIBOR plus a fixed margin which varied with the Company's credit rating. In the second quarter of 2023, the Credit Facility was amended so that borrowings under the Credit Facility bear interest at a rate per annum equal, at the Company's option, either at (a) Securities Overnight Financing Rate ("SOFR") benchmark rate for U.S. dollar borrowings, or (b) a currency specific benchmark rate, plus an applicable margin which varies with the Company's credit ratings. The Company is required to maintain certain coverage and leverage ratios for the Credit Facility, which are evaluated quarterly. | text | 3.5 | monetaryItemType | text: <entity> 3.5 </entity> <entity type> monetaryItemType </entity type> <context> In October 2023, the Company increased its multi-currency unsecured five-year revolving credit facility (the "Credit Facility") capacity to $ 3.5 billion from $ 2.8 billion and extended the expiration to October 2028. The interest rate on the Credit Facility was initially based on LIBOR plus a fixed margin which varied with the Company's credit rating. In the second quarter of 2023, the Credit Facility was amended so that borrowings under the Credit Facility bear interest at a rate per annum equal, at the Company's option, either at (a) Securities Overnight Financing Rate ("SOFR") benchmark rate for U.S. dollar borrowings, or (b) a currency specific benchmark rate, plus an applicable margin which varies with the Company's credit ratings. The Company is required to maintain certain coverage and leverage ratios for the Credit Facility, which are evaluated quarterly. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
In October 2023, the Company increased its multi-currency unsecured five-year revolving credit facility (the "Credit Facility") capacity to $ 3.5 billion from $ 2.8 billion and extended the expiration to October 2028. The interest rate on the Credit Facility was initially based on LIBOR plus a fixed margin which varied with the Company's credit rating. In the second quarter of 2023, the Credit Facility was amended so that borrowings under the Credit Facility bear interest at a rate per annum equal, at the Company's option, either at (a) Securities Overnight Financing Rate ("SOFR") benchmark rate for U.S. dollar borrowings, or (b) a currency specific benchmark rate, plus an applicable margin which varies with the Company's credit ratings. The Company is required to maintain certain coverage and leverage ratios for the Credit Facility, which are evaluated quarterly. | text | 2.8 | monetaryItemType | text: <entity> 2.8 </entity> <entity type> monetaryItemType </entity type> <context> In October 2023, the Company increased its multi-currency unsecured five-year revolving credit facility (the "Credit Facility") capacity to $ 3.5 billion from $ 2.8 billion and extended the expiration to October 2028. The interest rate on the Credit Facility was initially based on LIBOR plus a fixed margin which varied with the Company's credit rating. In the second quarter of 2023, the Credit Facility was amended so that borrowings under the Credit Facility bear interest at a rate per annum equal, at the Company's option, either at (a) Securities Overnight Financing Rate ("SOFR") benchmark rate for U.S. dollar borrowings, or (b) a currency specific benchmark rate, plus an applicable margin which varies with the Company's credit ratings. The Company is required to maintain certain coverage and leverage ratios for the Credit Facility, which are evaluated quarterly. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
In October 2023, the Company terminated its one-year uncommitted revolving credit facility (the "Uncommitted Credit Facility"). There were no borrowings outstanding under the Uncommitted Credit Facility at | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> In October 2023, the Company terminated its one-year uncommitted revolving credit facility (the "Uncommitted Credit Facility"). There were no borrowings outstanding under the Uncommitted Credit Facility at </context> | us-gaap:LineOfCredit |
The Company also maintains other credit and overdraft facilities with various financial institutions aggregating $ 123 million at December 31, 2024 and $ 113 million at December 31, 2023. | text | 123 | monetaryItemType | text: <entity> 123 </entity> <entity type> monetaryItemType </entity type> <context> The Company also maintains other credit and overdraft facilities with various financial institutions aggregating $ 123 million at December 31, 2024 and $ 113 million at December 31, 2023. </context> | us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount |
The Company also maintains other credit and overdraft facilities with various financial institutions aggregating $ 123 million at December 31, 2024 and $ 113 million at December 31, 2023. | text | 113 | monetaryItemType | text: <entity> 113 </entity> <entity type> monetaryItemType </entity type> <context> The Company also maintains other credit and overdraft facilities with various financial institutions aggregating $ 123 million at December 31, 2024 and $ 113 million at December 31, 2023. </context> | us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount |
The Company has outstanding guarantees and letters of credit with various banks aggregating $ 163 million and $ 139 million at December 31, 2024 and 2023, respectively. | text | 163 | monetaryItemType | text: <entity> 163 </entity> <entity type> monetaryItemType </entity type> <context> The Company has outstanding guarantees and letters of credit with various banks aggregating $ 163 million and $ 139 million at December 31, 2024 and 2023, respectively. </context> | us-gaap:LettersOfCreditOutstandingAmount |
The Company has outstanding guarantees and letters of credit with various banks aggregating $ 163 million and $ 139 million at December 31, 2024 and 2023, respectively. | text | 139 | monetaryItemType | text: <entity> 139 </entity> <entity type> monetaryItemType </entity type> <context> The Company has outstanding guarantees and letters of credit with various banks aggregating $ 163 million and $ 139 million at December 31, 2024 and 2023, respectively. </context> | us-gaap:LettersOfCreditOutstandingAmount |
In November 2024, the Company issued $ 7.25 billion in senior notes as follows: | text | 7.25 | monetaryItemType | text: <entity> 7.25 </entity> <entity type> monetaryItemType </entity type> <context> In November 2024, the Company issued $ 7.25 billion in senior notes as follows: </context> | us-gaap:DebtInstrumentFaceAmount |
$ 950 million 4.550 % senior notes due 2027; | text | 950 | monetaryItemType | text: <entity> 950 </entity> <entity type> monetaryItemType </entity type> <context> $ 950 million 4.550 % senior notes due 2027; </context> | us-gaap:DebtInstrumentFaceAmount |
$ 950 million 4.550 % senior notes due 2027; | text | 4.550 | percentItemType | text: <entity> 4.550 </entity> <entity type> percentItemType </entity type> <context> $ 950 million 4.550 % senior notes due 2027; </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
$ 1 billion 4.650 % senior notes due 2030; | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> $ 1 billion 4.650 % senior notes due 2030; </context> | us-gaap:DebtInstrumentFaceAmount |
$ 1 billion 4.650 % senior notes due 2030; | text | 4.650 | percentItemType | text: <entity> 4.650 </entity> <entity type> percentItemType </entity type> <context> $ 1 billion 4.650 % senior notes due 2030; </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
$ 1 billion 4.850 % senior notes due 2031; | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> $ 1 billion 4.850 % senior notes due 2031; </context> | us-gaap:DebtInstrumentFaceAmount |
$ 1 billion 4.850 % senior notes due 2031; | text | 4.850 | percentItemType | text: <entity> 4.850 </entity> <entity type> percentItemType </entity type> <context> $ 1 billion 4.850 % senior notes due 2031; </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
$ 2 billion 5.000 % senior notes due 2035; | text | 2 | monetaryItemType | text: <entity> 2 </entity> <entity type> monetaryItemType </entity type> <context> $ 2 billion 5.000 % senior notes due 2035; </context> | us-gaap:DebtInstrumentFaceAmount |
$ 2 billion 5.000 % senior notes due 2035; | text | 5.000 | percentItemType | text: <entity> 5.000 </entity> <entity type> percentItemType </entity type> <context> $ 2 billion 5.000 % senior notes due 2035; </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
$ 500 million 5.350 % senior notes due 2044; | text | 500 | monetaryItemType | text: <entity> 500 </entity> <entity type> monetaryItemType </entity type> <context> $ 500 million 5.350 % senior notes due 2044; </context> | us-gaap:DebtInstrumentFaceAmount |
$ 500 million 5.350 % senior notes due 2044; | text | 5.350 | percentItemType | text: <entity> 5.350 </entity> <entity type> percentItemType </entity type> <context> $ 500 million 5.350 % senior notes due 2044; </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
$ 1.5 billion 5.400 % senior notes due 2055; and | text | 1.5 | monetaryItemType | text: <entity> 1.5 </entity> <entity type> monetaryItemType </entity type> <context> $ 1.5 billion 5.400 % senior notes due 2055; and </context> | us-gaap:DebtInstrumentFaceAmount |
$ 1.5 billion 5.400 % senior notes due 2055; and | text | 5.400 | percentItemType | text: <entity> 5.400 </entity> <entity type> percentItemType </entity type> <context> $ 1.5 billion 5.400 % senior notes due 2055; and </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
$ 300 million floating rate senior notes due 2027 (the "Floating Notes"), | text | 300 | monetaryItemType | text: <entity> 300 </entity> <entity type> monetaryItemType </entity type> <context> $ 300 million floating rate senior notes due 2027 (the "Floating Notes"), </context> | us-gaap:DebtInstrumentFaceAmount |
For the Floating Notes, interest is calculated based on a compounded SOFR benchmark rate plus 0.700 %. | text | 0.700 | percentItemType | text: <entity> 0.700 </entity> <entity type> percentItemType </entity type> <context> For the Floating Notes, interest is calculated based on a compounded SOFR benchmark rate plus 0.700 %. </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.